Correction to: Modern Pathology 10.1038/s41379-022-01090-y, published online 19 May 2022
The original version of this article unfortunately contained mistakes. The errors are:
in Table 2: For LCNEC2, p53 IHC should be ++, not +
in Figure 4: the type of RB mutation for SCNEC6 is incorrect (box should be yellow not peach). The corrected table and figure can be found below. The original article has been corrected.
Table 2.
RB and p53 alterations in neuroendocrine carcinomas.
| Case ID | TP53 alteration | p53 IHC | RB1 alteration | RB IHC |
|---|---|---|---|---|
| SCNEC1 | p.Y126_R158del | − | p.D394fs | − |
| SCNEC2 | p.C238F | NP | c.2212-1G>C | − |
| SCNEC3 | Deep deletion | − | p.K202fs | − |
| SCNEC4 | c.993+1G>A | − | Deep deletion | − |
| SCNEC5 | p.G266E | + | c.2107-1G>C | − |
| SCNEC6 | p.R213L | NP | p.T197fs | NP |
| SCNEC7 | None | + | NP | − |
| ANEC1 | p.M133K | ++ | Deep deletion | − |
| ANEC2 | p.R248W | NP | Deep deletion | − |
| LCNEC1 | p.R342* | ++a | Rearrangement | − |
| LCNEC2 | p.Y163C | ++ | p.Y325fs | − |
| LCNEC3 | None | + | None | + |
| LCNEC4 | None | + | None | + |
−Negative (null); +Positive, non-diffuse (<90%); ++Positive, diffuse (≥90%).
IHC immunohistochemistry, NP not performed.
aNuclear and cytoplasmic staining.
